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CLINICAL EXPERIENCES WITH METHOXSALEN IN SUNTANNING
JOSEPH A. ELLIOTT, JR., M.D.
Charlotte, North Carolina
In 1955, Lerner reported (1) "that oral intake
of S-methoxypsoralen followed by exposure to
sunlight markedly increases the ability to tan.
The latter does not result from a simple lengthen-
ing of the time that one can be exposed to sun-
light but represents an actual potentiation of
tanning capacity." Fitzpatrick et al. (2) and
subsequently Arnold (3) and Becker (4) reported
similar results.
Clinical evaluation of the treatment of vitiligo
with oral methoxsalen confirmed these findings
to the extent that it was apparent that those
patients who did not show an unusual degree
of tanning of the normal skin were not following
the treatment regimen properly.
A double-blind placebo control study was
undertaken on 34 normal young adults, five
males and 29 females. Four males and four fe-
males did not complete the study. Each subject
ingested two 10 mg. capsules two hours before
exposure to sunshine at noon daily for two weeks.
Seven subjects were given a second lot of the
capsules: four the alternate capsule and three
the same capsule they had previously taken. In no
instance did the subject or I know the identity
of the capsule he was taking.
Two of 11 or 15 per cent of the subjects re-
ceiving placebos felt that they had greater than
normal tanning during the test period. Of the
19 subjects receiving methoxsalen, 15, or 80 per
cent, felt they received an increased degree of
tanning. Each of the four subjects receiving both
capsules felt they had no increased tanning with
the placebo and increased tanning with methox-
salen. One subject received the placebo in both
test periods and developed no increased tanning
either time. However, each of the two subjects
receiving methoxsalen in both test periods re-
ported increased tanning in the first test period
but not in the second. Three subjects receiving
Presented at the Brook Lodge Invitational
Symposium on the Psoralens, sponsored by The
Upjohn Company, Kalamazoo, Michigan, March
27—28, 1958.
339
methoxsalen reported they tanned well for the
first time in their lives and two reported that
they were able to be in the sun without burning
for the first time. One subject who had previously
had a polymorphous light eruption with exposure
to sunlight had none. One subject stopped treat-
ment because of itching although there was more
tanning than usual.
Of the 13 patients with vitiligo treated with
methoxsalen who used a General Electric R.S.
Sunlamp during the winter, none showed sig-
nificant tanning of the normal skin as compared
with the degree attained with exposure to natural
sunlight in the summer.
A controlled study was carried out on two
subjects using methoxsalen topically with ex-
posure of the skin to ultraviolet light. In one
instance, a one per cent methoxsalen solution
was applied to a four square inch patch on the
back and exposed to sunlight for 15 minutes.
This area became vesicular within 24 hours and
there was residual hyperpigmentation for more
than nine months. A similar area without meth-
oxsalen was exposed to sunlight for 45 minutes
with only slight erythema resultant in 24 hours.
On the other hand, a similar test with one per
cent methoxsalen solution, but using a Fisher
"cold" Mercury are lamp (2000—2600 A.), Model
no. 85C and a Burdiek quartz Mercury ultra-
violet lamp (3000—3200 A.), Model no. QS-
450-N resulted in no visual difference between
the areas painted with methoxsalen and those
not painted.
Interestingly, two patients with vitiligo re-
ported a persistent, increased sensitivity to
sunlight after treatment of their vitiligo with
methoxsalen for eight months in 1954 and 1955.
suMMARy AND CONCLU5ION5
This study confirms previous report, that
oral intake of methoxsalen followed by exposure
to sunlight increases the ability to tan through
potentiation of the tanning capacity.
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